General Information of the Compound
Compound ID
CP0925213
Compound Name
4-Pyridin-3-yl-1-[3-(trifluoromethyl)[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-ol
    Show/Hide
Structure
Formula
C16H15F3N6O
Molecular Weight
364.331
Canonical SMILES
OC1(c2cccnc2)CCN(c2ccc3nnc(C(F)(F)F)n3n2)CC1
    Show/Hide
InChI
InChI=1S/C16H15F3N6O/c17-16(18,19)14-22-21-12-3-4-13(23-25(12)14)24-8-5-15(26,6-9-24)11-2-1-7-20-10-11/h1-4,7,10,26H,5-6,8-9H2
    Show/Hide
InChIKey
GEVVHUGVIJRPPF-UHFFFAOYSA-N
Physicochemical Property
logP
2.0261
Rotatable Bonds
2
Heavy Atom Count
26
Polar Areas
79.44
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
7
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44125830
SID: 84977667
ChEMBL ID
CHEMBL2346971
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00894, Androgen receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000141 LNCaP Homo sapiens (Human)  1
1
IC50 = 10715.19 nM
   TI
   LI
   LO
   TS